Sleep–inducing effects of carbamazepine (tegretol) and clorazepate (tranxene) in the primary persistent insomnia
| dc.contributor.author | Maximov, G. | |
| dc.contributor.author | Maximov, K. | |
| dc.date.accessioned | 2012-05-04T12:59:24Z | |
| dc.date.available | 2012-05-04T12:59:24Z | |
| dc.date.issued | 2008-06 | |
| dc.description | Address for correspondence: Gueorgui Konstantinov Maximov Military Medical Academy Medical Center for Neurology and Neurosurgery 3, G. Sofiyski str. 1601 Sofia Bulgaria e_mail: neuromaxi@yahoo.com | en_US |
| dc.description.abstract | Primary persistent insomnia (PPI) occurs independently of any known physical or mental condition and is among the most difficult problems in sleep disorders. For the treatment of PPI, comedication of clorazepate (Tranxene) in dosage 1 capsule of 10 mg and carbamazepine (Tegretol) in dosage 1 tablet of 200 mg in 32 out-patients for 30 days was applied. Normalization of sleep was achieved in 29 patients (90,63%). Side effects were few (5 patients) and of little importance, and the treatment was well tolerated. | en_US |
| dc.identifier.citation | Maximov, G., and K. Maximov. Sleep–inducing effects of carbamazepine (tegretol) and clorazepate (tranxene) in the primary persistent insomnia - Acta Medica Bulgarica, 35, 2008, № 1, 19-24. | en_US |
| dc.identifier.issn | 0324-1750 | |
| dc.identifier.uri | http://hdl.handle.net/10861/145 | |
| dc.language.iso | en | en_US |
| dc.publisher | Централна медицинска библиотека, МУ София / Central Medical Library - MU Sofia | en_US |
| dc.subject | primary persistent insomnia, clorazepate (Tranxene), carbamazepine (Tegretol) | en_US |
| dc.title | Sleep–inducing effects of carbamazepine (tegretol) and clorazepate (tranxene) in the primary persistent insomnia | en_US |
| dc.type | Article | en_US |